Epidermal growth factor receptor (EGFR) belongs to a family of four receptors (EGFR, ErbB2, ErbB3 and ErbB4) and is the best-known and established oncogenic target in advanced and metastatic NSCLC [6,7]. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.